Cost analysis of daratumumab therapy: Is there a cost benefit to using the recently approved subcutaneous product versus the IV product?

Janssen Biotech, Inc. Darzalex (package insert). Pennsylvania: Janssen Biotech, Inc., 2020.

Center for Drug Evaluation and Research. FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma. https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-daratumumab-and-hyaluronidase-fihj-multiple-myeloma (2020, accessed 2 December 2020).

Center for Drug Evaluation and Research. Daratumumab (DARZALEX), www.fda.gov/drugs/resources-information-approved-drugs/daratumumab-darzalex (2016, accessed 2 December 2020).

Janssen Biotech, Inc. Darzalex faspro (package insert). Pennsylvania: Janssen Biotech, Inc., 2020.